Dr. Cragun is an assistant professor at the University of Arizona. She specializes in the diagnosis and treatment of gynecologic cancers such as endometrial and ovarian cancers as well as rare reproductive cancers, abnormal pap smears, high-risk cancer screening and fertility preservation.
Before completing the gynecologic oncology fellowship program at the University of South Florida in Tampa, Dr. Cragun earned her medical degree at the University of Utah School of Medicine, Salt Lake City, Utah; completed a residency in obstetrics and gynecology at Duke University Medical Center, Durham, North Carolina, and pursued a post-doctoral research fellowship at H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.
Currently, gynecologic cancers account for about 12 percent of all cancers which affect US women. Ovarian cancer alone is the fifth most common cause of cancer death in women. Dr. Cragun’s recent research studies include gene expression in older versus younger women with ovarian cancers responsive to cisplatin, and microRNA associated with development of cisplatin resistance.
Dr. Cragun currently sits on the Scientific Review Committee of the University of Arizona Cancer Center (UACC). She participates in clinical trials opened by the gynecologic oncology division at the University of Arizona, including both cooperative studies through the NRG as well as investigator initiated trials. She has acted as the site PI some of these trials (GOG 252, GOG 225, GOG 86P). As a gynecologic oncologist she has both surgical and chemotherapeutic background. Dr. Cragun brings these experiences to the scientific review committee as they review studies proposed for the UACC.
Specialty: Gynecologic Oncology
Clinical Focus: Dr. Cragun specializes in the diagnosis and treatment of gynecologic cancers to include:
- Ovarian Cancer
- Uterine Cancer
- Cervical Cancer
- Vulvar, Vaginal Cancer
- Gestational Trophoblastic Disease
- Complicated Gynecologic Surgery
- Premalignant Conditions of Cervix, Uterus, Vulva
- Abnormal Pap Smears
- High-Risk Cancer Screening
- Fertility Preservation
- Second Opinions
Disease or Clinical Specialty: